Uroplasty to Issue Fourth Fiscal Quarter and Full Year Results on June 4, 2009

* Reuters is not responsible for the content in this press release.

Tue May 19, 2009 6:30am EDT 

MINNEAPOLIS, May 19 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (Amex: UPI)
announced today that it will release financial results for the fourth fiscal
quarter and full year ended March 31, 2009, at the market close on Thursday,
June 4, 2009.  The Company will host a conference call to discuss these
results on Thursday, June 4, 2009 at 3:30 p.m. Central Time.  David Kaysen,
President and Chief Executive Officer, and Medi Jiwani, Vice President, Chief
Financial Officer and Treasurer, will host the call.  Individuals wishing to
participate in the conference call should dial 877-941-8609 (domestic) or
480-629-9818 (international).  An audio replay will be available for 30 days
following the call at 800-406-7325 (domestic) or 303-590-3030 (international),
with the passcode 4081844 #.

About Uroplasty, Inc. 
Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with wholly-owned
subsidiaries in The Netherlands and the United Kingdom, is a medical device
company that develops, manufactures and markets innovative proprietary
products for the treatment of voiding dysfunctions.  Our primary focus is on
sales growth in the U.S. market.  We offer the Urgent PC(R) system, which we
believe is the only FDA-approved minimally invasive nerve stimulation device
designed for office-based treatment of urinary urgency, urinary frequency and
urge incontinence - symptoms often associated with overactive bladder.  We
also offer Macroplastique(R) Implants, an injectable bulking agent for the
treatment of adult female stress urinary incontinence primarily due to
intrinsic sphincter deficiency.  Please visit Uroplasty, Inc. at
www.uroplasty.com. 

    For Further Information: Uroplasty, Inc.         EVC Group
    David Kaysen, President and CEO, or              Doug Sherk/(Investors)
    Medi Jiwani, Vice President, CFO, and            415.896.6820
    Treasurer,                                       Chris Gale/Steve DiMattia
    952.426.6140                                    (Media)
                                                     646.201.5431


 


SOURCE  Uroplasty, Inc.

David Kaysen, President and CEO, or Medi Jiwani, Vice President, CFO, and
Treasurer, both at +1-952-426-6140, both of Uroplasty, Inc.; or Investors,
Doug Sherk, +1-415-896-6820, or Media, Chris Gale, or Steve DiMattia, both at
+1-646-201-5431, all of EVC Group, for Uroplasty, Inc.
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.